Innate Pharma (IPHA) Stock Chart & Stock Price History $1.98 -0.03 (-1.58%) As of 10:38 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Innate Pharma Stock Price Performance The Innate Pharma (IPHA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 19.53%, with a year-to-date return of 7.58%. In the past month, the stock has decreased 12.99%, reflecting recent market activity. As of the latest close, Innate Pharma traded at $1.98 with a market cap of $182.14 million and volume of 10,649 shares. Five years ago, the stock traded at $5.92, representing a 66.56% decrease over that period. At the time, it had a market cap of $483.73 million and a volume of 9,200 shares. Receive IPHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.93%1 Month Performance-12.99%3 Month Performance-1.76%Year-To-Date Performance+7.58%1 Year Performance-19.53%5 Year Performance-66.56% IPHA Stock Chart for Thursday, June, 12, 2025 IPHA Chart by TradingView Innate Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$1.98$1.98-0.20%$2.02$1.9410,649 shs$182.14 million06/10/2025$2.12$1.98-6.38%$2.04$1.968,448 shs$182.51 million06/09/2025$2.15$2.12-1.63%$2.15$2.074,131 shs$194.95 million06/06/2025$2.15$2.15$2.19$2.139,610 shs$198.18 million06/05/2025$2.14$2.15+0.47%$2.21$2.0213,662 shs$198.18 million06/04/2025$2.14$2.14$2.20$2.143,813 shs$197.26 million06/03/2025$2.14$2.14-0.05%$2.15$2.126,412 shs$197.26 million06/02/2025$2.16$2.14-0.88%$2.18$2.143,163 shs$197.35 million05/30/2025$2.20$2.16-1.82%$2.21$2.068,120 shs$199.10 million05/29/2025$2.14$2.20+2.80%$2.24$2.1210,752 shs$202.79 million Get the Latest News and Ratings for IPHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$2.16$2.14-0.93%$2.18$2.142,185 shs$197.26 million05/27/2025$2.16$2.16+0.23%$2.20$2.1112,162 shs$199.10 million05/26/2025$2.16$2.16$2.20$2.137,065 shs$198.64 million05/23/2025$2.18$2.16-1.15%$2.20$2.137,065 shs$180.65 million05/22/2025$2.14$2.18+1.87%$2.18$2.106,697 shs$182.75 million05/21/2025$2.12$2.14+0.94%$2.18$2.1413,623 shs$179.40 million05/20/2025$2.08$2.12+1.92%$2.16$2.1018,880 shs$177.72 million05/19/2025$2.12$2.08-1.65%$2.17$2.0818,218 shs$174.37 million05/16/2025$2.11$2.12+0.24%$2.12$2.069,045 shs$177.30 million05/15/2025$2.08$2.11+1.44%$2.15$2.1010,375 shs$176.88 million05/14/2025$2.04$2.08+1.96%$2.19$2.0816,852 shs$174.37 million05/13/2025$2.28$2.04-10.33%$2.32$2.0284,124 shs$171.01 million05/12/2025$2.44$2.28-6.76%$2.42$2.2722,879 shs$190.71 million Related Companies CRON Stock Price Chart VIR Stock Price Chart ABCL Stock Price Chart IOVA Stock Price Chart KALV Stock Price Chart IMTX Stock Price Chart DAWN Stock Price Chart SION Stock Price Chart ORIC Stock Price Chart XERS Stock Price Chart Receive IPHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IPHA) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IPHA Stock Free IPHA Stock Alerts